Cochrane Review: Brexanolone, zuranolone and related neurosteroid GABA(A) receptor positive allosteric modulators for postnatal depression

Zusammenfassung

Brexanolon, Zuranolon und verwandte positive allosterische Modulatoren von Neurosteroiden am GABA A ‐Rezeptor zur Behandlung postnataler Depressionen - Wilson, CA - 2025 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014624.pub2/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD014624.pub2/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about ou

Kerninformationen

y.com/cdsr/doi/10.1002/14651858.CD014624.pub2/full/de#) [Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention Collapse all Expand all ## Abstract available in ### Background Postnatal depression – depression that occur...

of depression, including postnatal depression, and have a different mechanism of action than traditional antidepressants. ### Objectives To assess the benefits and harms of brexanolone, zuranolone and related neurosteroid GABAA receptor positive allosteric modulators compared to another active tr...

during the first 12 months following childbirth that compared neurosteroid GABAA receptor positive allosteric modulators with any other treatment (pharmacological, psychological or psychosocial), placebo or treatment as usual. ### Data collection and analysis We used standard Cochrane methodologi...

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen